Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTFeline heartworm diagnostic testingUnderstanding the new American Heartworm Society guidelines, why and when to screen cats for heartworm infection. +